Quebec SEAO #INSPQ-10829

EUROIMMUN ELISA kits for Strongyloides and Chikungunya testing

The Institut national de santé publique du Québec (INSPQ), through its Québec Public Health Laboratory (LSPQ), plans to procure infectious-disease testing kits from EUROIMMUN. - Buyer: Institut national de santé publique du Québec (INSPQ), Québec Public Health Laboratory (LSPQ). - Named OEM: EUROIMMUN. - Products requested: - 75 Anti-Strongyloides ELISA (IgG) kits, part number EI 2290-9601 G. - 9 Anti-Chikungunya Virus ELISA (IgM) kits, part number EI 293a-9601 M. - 4 Anti-Chikungunya Virus ELISA (IgG) kits, part number EI 293a-9601 G. - Notable requirements and rationale: The kits are intended for immunoenzymatic infectious-disease testing. The INSPQ cites analytical performance, compatibility with laboratory automation, Health Canada authorization, and experience or recommendations involving other provincial laboratories and the National Microbiology Laboratory as reasons the EUROIMMUN products meet its needs.

Description

The Institut national de santé publique du Québec intends to award a supply contract for immunoenzymatic kits and associated quality controls used to screen for infectious diseases. The planned 2027 purchases are 75 Anti-Strongyloides ELISA (IgG) kits, 9 Anti-Chikungunya Virus ELISA (IgM) kits, and 4 Anti-Chikungunya Virus ELISA (IgG) kits, with EUROIMMUN identified as the intended supplier. This is a notice of intent, not a competitive call for tenders; suppliers who believe they meet the requirements may respond by November 13, 2026, at 3:00 p.m. Québec time. The planned contract period is January 1 through December 31, 2027, and the estimated value is not disclosed.

View original listing